Table 4.
Clinical characteristics for athletes with incidental cardiovascular diagnoses
| Case | Age (years) |
Sex | ECG | TTE | Additional testing | Final diagnosis |
|---|---|---|---|---|---|---|
| 1 | 19 | F | Normal | ASA | – | ASA |
| 2 | 22 | M | Normal | Cor triatriatum | – | Cor triatriatum |
| 3 | 22 | F | Normal | PFO | – | PFO |
| 4 | 18 | F | Normal | Possible PFO | – | Possible PFO |
| 5 | 19 | F | Normal | Possible PFO | – | Possible PFO |
| 6 | 21 | F | Normal | Possible PFO | – | Possible PFO |
| 7 | 20 | M | Normal | Mild MV calcifications, aortic sclerosis without stenosis | – | Mild MV calcifications, aortic sclerosis |
| 8 | 20 | M | Normal | Inferoapical LV trabeculation, mild global hypokinesis | – | Possible limited LVNC, LV trabeculation |
| 9 | 20 | M | Normal | Mild concentric LVH (IVS 13 mm) | – | LVH, mild |
| 10 | 19 | M | Normal | PFO versus ASD | – | PFO versus ASD |
| 11 | 18 | F | Normal | PFO versus ASD | – | PFO versus ASD |
| 12 | 19 | F | Normal | ASA | CMR: moderate-to-severe BiV enlargement | ASA |
| 13 | 20 | F | Normal | ASA | CMR: normal | ASA |
| 14 | 19 | M | Normal | Aortic arch outpouching | CTA chest: bovine aortic arch | Bovine aortic arch |
| 15 | 19 | F | Normal | PFO, ASA | – | PFO, ASA |
| 16 | 19 | F | Normal | PFO | – | PFO |
| 17 | 21 | M | Normal | PFO | – | PFO |
| 18 | 22 | M | Normal | PFO | – | PFO |
| 19 | 21 | F | Normal | Tricuspid vegetation versus artefact | TEE recommended, not done | Tricuspid vegetation versus artefact |
| 20 | 19 | M | Normal | GLS 14% | – | Normal/Athlete’s heart |
| 21 | 19 | M | Normal | GLS 13% | – | Normal/Athlete’s heart |
| 22 | 20 | M | Normal | Mildly reduced GLS | – | Normal/Athlete’s heart |
| 23 | 19 | M | Normal | Mildly reduced GLS | – | Normal/Athlete’s heart |
| 24 | 21 | F | Normal | GLS 15.7%; minimal basal inferior/inferoseptal WMA | – | Normal/Athlete’s heart |
| 25 | 22 | M | Normal | Septal hypokinesis | – | Normal/Athlete’s heart |
ASA, atrial septal aneurysm; ASD, atrial septal defect; BiV, biventricular; CMR, cardiac magnetic resonance; CTA, CT angiography; F, female; GLS, global longitudinal strain; IVS, intraventricular septum; LV, left ventricle; LVEF, left ventricular ejection fraction; LVNC, left ventricular non-compaction; M, male; MV, mitral valve; PFO, patent foramen ovale; TEE, trans-oesophageal echocardiography; TTE, transthoracic echocardiography; WMA, wall motion abnormalities.